nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CHRM3—ureter—cervical cancer	0.146	0.287	CbGeAlD
Promazine—CHRM3—exocrine gland—cervical cancer	0.0287	0.0565	CbGeAlD
Promazine—CHRM5—epithelium—cervical cancer	0.0223	0.0439	CbGeAlD
Promazine—ADRA1D—epithelium—cervical cancer	0.02	0.0393	CbGeAlD
Promazine—ADRA1B—renal system—cervical cancer	0.0189	0.0372	CbGeAlD
Promazine—ADRA1D—female reproductive system—cervical cancer	0.0148	0.0292	CbGeAlD
Promazine—CHRM3—renal system—cervical cancer	0.0116	0.0228	CbGeAlD
Promazine—ADRA1A—epithelium—cervical cancer	0.0115	0.0226	CbGeAlD
Promazine—HTR2C—female reproductive system—cervical cancer	0.011	0.0216	CbGeAlD
Promazine—ADRA1A—renal system—cervical cancer	0.0106	0.0209	CbGeAlD
Promazine—CHRM1—female reproductive system—cervical cancer	0.0104	0.0204	CbGeAlD
Promazine—CHRM3—female reproductive system—cervical cancer	0.00928	0.0182	CbGeAlD
Promazine—HRH1—epithelium—cervical cancer	0.00888	0.0175	CbGeAlD
Promazine—HRH1—uterine cervix—cervical cancer	0.0088	0.0173	CbGeAlD
Promazine—CYP1A2—renal system—cervical cancer	0.0088	0.0173	CbGeAlD
Promazine—ADRA2A—uterine cervix—cervical cancer	0.00865	0.017	CbGeAlD
Promazine—CHRM3—female gonad—cervical cancer	0.00844	0.0166	CbGeAlD
Promazine—HRH1—decidua—cervical cancer	0.00839	0.0165	CbGeAlD
Promazine—ADRA2A—decidua—cervical cancer	0.00824	0.0162	CbGeAlD
Promazine—HRH1—endometrium—cervical cancer	0.00796	0.0157	CbGeAlD
Promazine—ADRA2A—endometrium—cervical cancer	0.00782	0.0154	CbGeAlD
Promazine—CYP2C19—vagina—cervical cancer	0.0078	0.0153	CbGeAlD
Promazine—HRH1—mammalian vulva—cervical cancer	0.0077	0.0151	CbGeAlD
Promazine—ADRA2A—mammalian vulva—cervical cancer	0.00756	0.0149	CbGeAlD
Promazine—HTR2A—epithelium—cervical cancer	0.00742	0.0146	CbGeAlD
Promazine—ADRA2A—uterus—cervical cancer	0.00721	0.0142	CbGeAlD
Promazine—HTR2A—renal system—cervical cancer	0.00688	0.0135	CbGeAlD
Promazine—CYP2C9—female reproductive system—cervical cancer	0.00669	0.0132	CbGeAlD
Promazine—HRH1—female reproductive system—cervical cancer	0.0066	0.013	CbGeAlD
Promazine—ADRA2A—female reproductive system—cervical cancer	0.00648	0.0127	CbGeAlD
Promazine—CYP3A4—renal system—cervical cancer	0.00637	0.0125	CbGeAlD
Promazine—HRH1—female gonad—cervical cancer	0.006	0.0118	CbGeAlD
Promazine—HRH1—vagina—cervical cancer	0.00596	0.0117	CbGeAlD
Promazine—ADRA2A—female gonad—cervical cancer	0.00589	0.0116	CbGeAlD
Promazine—ADRA2A—vagina—cervical cancer	0.00586	0.0115	CbGeAlD
Promazine—HTR2A—female reproductive system—cervical cancer	0.00551	0.0108	CbGeAlD
Promazine—CYP3A4—female reproductive system—cervical cancer	0.0051	0.01	CbGeAlD
Promazine—HTR2A—vagina—cervical cancer	0.00498	0.0098	CbGeAlD
Promazine—HRH1—lymph node—cervical cancer	0.00386	0.00759	CbGeAlD
Promazine—ADRA2A—lymph node—cervical cancer	0.00379	0.00745	CbGeAlD
Promazine—CHRM1—Signaling Pathways—TAAR6—cervical cancer	0.000451	0.000918	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—WNT5A—cervical cancer	0.00045	0.000916	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TAAR6—cervical cancer	0.00045	0.000915	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—WNT5A—cervical cancer	0.000446	0.000907	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TAAR6—cervical cancer	0.000445	0.000906	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000445	0.000905	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000444	0.000904	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKAP13—cervical cancer	0.000439	0.000893	CbGpPWpGaD
Promazine—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.000428	0.000871	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000418	0.000851	CbGpPWpGaD
Promazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000413	0.000841	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000413	0.000841	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.000413	0.00084	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000413	0.00084	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000408	0.00083	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.000401	0.000816	CbGpPWpGaD
Promazine—CHRM3—Metabolism—CA9—cervical cancer	0.000396	0.000807	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—WNT5A—cervical cancer	0.000396	0.000805	CbGpPWpGaD
Promazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000396	0.000805	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.00039	0.000794	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—WNT5A—cervical cancer	0.000379	0.000771	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—CA9—cervical cancer	0.000364	0.00074	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000361	0.000735	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.00036	0.000732	CbGpPWpGaD
Promazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000359	0.00073	CbGpPWpGaD
Promazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000358	0.000729	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000358	0.000728	CbGpPWpGaD
Promazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000357	0.000726	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000356	0.000725	CbGpPWpGaD
Promazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000356	0.000724	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000354	0.00072	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000353	0.000719	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.000352	0.000717	CbGpPWpGaD
Promazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000351	0.000715	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—WNT2—cervical cancer	0.000351	0.000714	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.000348	0.000707	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000347	0.000705	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000343	0.000697	CbGpPWpGaD
Promazine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000323	0.000658	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000322	0.000655	CbGpPWpGaD
Promazine—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.000316	0.000644	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000316	0.000643	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000311	0.000632	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.00031	0.000631	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.000309	0.000629	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000309	0.000629	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKAP13—cervical cancer	0.000308	0.000627	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000305	0.000621	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000304	0.000619	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000296	0.000602	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000283	0.000575	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000282	0.000573	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—NOTCH2—cervical cancer	0.000278	0.000565	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000273	0.000555	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000268	0.000546	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000268	0.000545	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—WNT5A—cervical cancer	0.000267	0.000543	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—WNT5A—cervical cancer	0.000266	0.000541	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—NOTCH2—cervical cancer	0.000266	0.000541	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.000263	0.000536	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000263	0.000535	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CA9—cervical cancer	0.000258	0.000524	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000253	0.000516	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.00025	0.000509	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000244	0.000497	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CA9—cervical cancer	0.000235	0.000478	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HES1—cervical cancer	0.000231	0.00047	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HES1—cervical cancer	0.000228	0.000463	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HES1—cervical cancer	0.000218	0.000444	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000217	0.000441	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HES1—cervical cancer	0.000208	0.000423	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000208	0.000422	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000205	0.000417	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TERT—cervical cancer	0.000202	0.000412	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CA9—cervical cancer	0.000201	0.000409	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TERT—cervical cancer	0.0002	0.000406	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000191	0.000389	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TERT—cervical cancer	0.000191	0.000389	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000188	0.000383	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000188	0.000382	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000187	0.000381	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	0.000187	0.00038	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.000186	0.000378	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	0.000185	0.000376	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000184	0.000375	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—FGFR3—cervical cancer	0.000183	0.000373	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TERT—cervical cancer	0.000182	0.000371	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.00018	0.000366	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000178	0.000362	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	0.000175	0.000357	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000174	0.000355	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	0.000172	0.00035	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000171	0.000349	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.00017	0.000346	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000167	0.00034	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000165	0.000336	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	0.000165	0.000335	CbGpPWpGaD
Promazine—CHRM3—Metabolism—MTHFR—cervical cancer	0.000161	0.000327	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HES1—cervical cancer	0.000157	0.000319	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000157	0.000319	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000156	0.000317	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000155	0.000316	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CA9—cervical cancer	0.000155	0.000315	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000155	0.000315	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000154	0.000314	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HES1—cervical cancer	0.000154	0.000313	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HES1—cervical cancer	0.000154	0.000312	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	0.000153	0.000312	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HES1—cervical cancer	0.000153	0.000311	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HES1—cervical cancer	0.000152	0.000308	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000151	0.000308	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000149	0.000303	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000148	0.0003	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	0.000147	0.000299	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000143	0.000291	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.00014	0.000286	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.00014	0.000284	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—TP53—cervical cancer	0.000138	0.000281	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000138	0.000281	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TERT—cervical cancer	0.000138	0.00028	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000137	0.000278	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000135	0.000275	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TERT—cervical cancer	0.000135	0.000275	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TERT—cervical cancer	0.000135	0.000274	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000273	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TERT—cervical cancer	0.000134	0.000273	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TERT—cervical cancer	0.000133	0.00027	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000132	0.00027	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000131	0.000266	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—MTOR—cervical cancer	0.000129	0.000262	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000128	0.000261	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000126	0.000257	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000124	0.000253	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.000124	0.000252	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	0.000123	0.000251	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—MTOR—cervical cancer	0.000123	0.000251	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	0.000123	0.00025	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000123	0.00025	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	0.000122	0.000248	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000122	0.000247	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000244	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.00012	0.000243	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CASP3—cervical cancer	0.000119	0.000241	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000118	0.000241	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—MTOR—cervical cancer	0.000118	0.000239	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000117	0.000237	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	0.000116	0.000237	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	0.000116	0.000236	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	0.000116	0.000236	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000236	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	0.000116	0.000235	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.000114	0.000233	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	0.000114	0.000233	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	0.000114	0.000232	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.000114	0.000232	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CASP3—cervical cancer	0.000113	0.000231	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000113	0.00023	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	0.000109	0.000223	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000108	0.00022	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	0.000107	0.000217	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000106	0.000216	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000106	0.000215	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—MTHFR—cervical cancer	0.000105	0.000213	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000104	0.000212	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000104	0.000211	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—EGFR—cervical cancer	0.000104	0.000211	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	0.000103	0.00021	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	0.000103	0.00021	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	0.000103	0.000209	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	0.000102	0.000207	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	0.000102	0.000207	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—STAT3—cervical cancer	0.000101	0.000205	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000101	0.000205	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—STAT3—cervical cancer	9.96e-05	0.000203	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	9.63e-05	0.000196	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—MTHFR—cervical cancer	9.54e-05	0.000194	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—STAT3—cervical cancer	9.54e-05	0.000194	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	9.45e-05	0.000192	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CASP3—cervical cancer	9.25e-05	0.000188	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—EGFR—cervical cancer	9.17e-05	0.000187	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—STAT3—cervical cancer	9.09e-05	0.000185	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—EGFR—cervical cancer	9.05e-05	0.000184	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	8.97e-05	0.000182	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	8.92e-05	0.000181	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MTOR—cervical cancer	8.88e-05	0.000181	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	8.86e-05	0.00018	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MTOR—cervical cancer	8.73e-05	0.000178	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MTOR—cervical cancer	8.72e-05	0.000177	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MTOR—cervical cancer	8.69e-05	0.000177	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EGFR—cervical cancer	8.67e-05	0.000176	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MTOR—cervical cancer	8.66e-05	0.000176	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MTOR—cervical cancer	8.58e-05	0.000174	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	8.55e-05	0.000174	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	8.54e-05	0.000174	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EGFR—cervical cancer	8.26e-05	0.000168	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CASP3—cervical cancer	8.16e-05	0.000166	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—MTHFR—cervical cancer	8.15e-05	0.000166	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	8.15e-05	0.000166	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CASP3—cervical cancer	8.03e-05	0.000163	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CASP3—cervical cancer	8.02e-05	0.000163	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CASP3—cervical cancer	7.99e-05	0.000163	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CASP3—cervical cancer	7.97e-05	0.000162	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	7.95e-05	0.000162	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CASP3—cervical cancer	7.89e-05	0.00016	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	7.87e-05	0.00016	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	7.87e-05	0.00016	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—STAT3—cervical cancer	7.77e-05	0.000158	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	7.74e-05	0.000158	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	7.73e-05	0.000157	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	7.7e-05	0.000157	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TP53—cervical cancer	7.7e-05	0.000157	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	7.68e-05	0.000156	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	7.6e-05	0.000155	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—cervical cancer	7.6e-05	0.000155	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	7.58e-05	0.000154	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	7.44e-05	0.000151	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	7.31e-05	0.000149	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—cervical cancer	7.28e-05	0.000148	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EGFR—cervical cancer	7.06e-05	0.000144	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	7.05e-05	0.000143	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—cervical cancer	6.93e-05	0.000141	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—cervical cancer	6.86e-05	0.00014	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—cervical cancer	6.84e-05	0.000139	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	6.76e-05	0.000138	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—cervical cancer	6.75e-05	0.000137	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—cervical cancer	6.74e-05	0.000137	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—cervical cancer	6.71e-05	0.000137	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—cervical cancer	6.69e-05	0.000136	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—cervical cancer	6.63e-05	0.000135	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	6.61e-05	0.000134	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTHFR—cervical cancer	6.29e-05	0.000128	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EGFR—cervical cancer	6.24e-05	0.000127	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	6.14e-05	0.000125	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EGFR—cervical cancer	6.13e-05	0.000125	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EGFR—cervical cancer	6.12e-05	0.000125	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EGFR—cervical cancer	6.1e-05	0.000124	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EGFR—cervical cancer	6.08e-05	0.000124	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EGFR—cervical cancer	6.02e-05	0.000123	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	6.01e-05	0.000122	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—cervical cancer	5.93e-05	0.000121	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—cervical cancer	5.68e-05	0.000116	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	5.58e-05	0.000114	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—cervical cancer	5.24e-05	0.000107	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—cervical cancer	5.15e-05	0.000105	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—cervical cancer	5.14e-05	0.000105	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—cervical cancer	5.12e-05	0.000104	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—cervical cancer	5.11e-05	0.000104	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—cervical cancer	5.06e-05	0.000103	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—cervical cancer	5.04e-05	0.000103	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—cervical cancer	4.69e-05	9.54e-05	CbGpPWpGaD
